A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression-Reference-Cited by-同舟云学术

A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression

Published:2018-06-05 Issue:6 Volume:13 Page:e0198116
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Blasco Hélène^ORCID,Patin Franck,Descat Amandine,Garçon Guillaume,Corcia Philippe,Gelé Patrick,Lenglet Timothée,Bede Peter,Meininger Vincent,Devos David,Gossens Jean François,Pradat Pierre-François

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?;H Mitsumoto;Lancet Neurol,2014

2. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS;E Beghi;Amyotroph Lateral Scler Frontotemporal Degener,2013

3. A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS;ME Bozik;Amyotroph Lateral Scler Frontotemporal Degener,2014

4. Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound;T Bordet;Pharmaceuticals (Basel),2010

5. Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis;LJ Martin;IDrugs,2010

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosis;Annals of the New York Academy of Sciences;2024-05-21

2. Unlocking the secrets of metabolomics with Artificial Intelligence: a comprehensive literature review;J PEDIATR NEONATAL I;2024

3. Harnessing Big Data in Amyotrophic Lateral Sclerosis: Machine Learning Applications for Clinical Practice and Pharmaceutical Trials;Journal of Integrative Neuroscience;2024-03-18

4. Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis;Cells;2024-01-29

5. From use of omics to systems biology: Identifying therapeutic targets for amyotrophic lateral sclerosis;International Review of Neurobiology;2024